Cargando…
Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain
BACKGROUND: L-acetylcarnitine, a drug marketed for the treatment of chronic pain, causes analgesia by epigenetically up-regulating type-2 metabotropic glutamate (mGlu2) receptors in the spinal cord. Because the epigenetic mechanisms are typically long-lasting, we hypothesized that analgesia could ou...
Autores principales: | Notartomaso, Serena, Mascio, Giada, Bernabucci, Matteo, Zappulla, Cristina, Scarselli, Pamela, Cannella, Milena, Imbriglio, Tiziana, Gradini, Roberto, Battaglia, Giuseppe, Bruno, Valeria, Nicoletti, Ferdinando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407675/ https://www.ncbi.nlm.nih.gov/pubmed/28326943 http://dx.doi.org/10.1177/1744806917697009 |
Ejemplares similares
-
N-Acetyl-cysteine causes analgesia by reinforcing the endogenous activation of type-2 metabotropic glutamate receptors
por: Bernabucci, Matteo, et al.
Publicado: (2012) -
Perineuronal nets are under the control of type-5 metabotropic glutamate receptors in the developing somatosensory cortex
por: Mascio, Giada, et al.
Publicado: (2021) -
mGlu1 Receptors Monopolize the Synaptic Control of Cerebellar Purkinje Cells by Epigenetically Down-Regulating mGlu5 Receptors
por: Notartomaso, Serena, et al.
Publicado: (2018) -
Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1
por: Notartomaso, Serena, et al.
Publicado: (2013) -
N-Acetylcysteine causes analgesia in a mouse model of painful
diabetic neuropathy
por: Notartomaso, Serena, et al.
Publicado: (2020)